| AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter ... - Reuters |
|
|
ReutersThis deferred revenue was primarily associated with a launch incentive program implemented to advance the adoption of Feraheme by dialysis organizations. ... read more |